Market cap
$4 Mln
Revenue (TTM)
$9 Mln
P/E Ratio
--
P/B Ratio
0.3
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.5 %
-
ROCE
-- %
-
Industry P/E
37.32
-
EV/EBITDA
-1.6
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$5
-
Face value
--
-
Shares outstanding
1,349,960
10 Years Aggregate
CFO
$-47.42 Mln
EBITDA
$-51.24 Mln
Net Profit
$-102.24 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Guardion Health Sciences (GHSI)
| -- | -- | -1.5 | -38.3 | -50.2 | -49.3 | -- |
|
BSE Sensex*
| -9.6 | -2.7 | 2.9 | -5.0 | 5.4 | 5.7 | 10.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2023
|
2022
|
2021
|
2020
|
|---|---|---|---|---|
|
Guardion Health Sciences (GHSI)
| -26.4 | -77.6 | -74.0 | 88.6 |
|
S&P Small-Cap 600
| 13.9 | -17.4 | 25.3 | 9.6 |
|
BSE Sensex
| 18.7 | 4.4 | 22.0 | 15.8 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Guardion Health Sciences (GHSI)
Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. The company offers GlaucoCetin, a dietary supplement to... support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health; and Lumega-Z, a medical food that replenishes and restores the macular protective pigment. It also provides Viactiv Omega Boost Gel Bites, an omega-3 fish oil dietary supplement. The company distributes medical foods products through e-commerce website, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in Houston, California. Read more
-
Independent Chairman & Secretary
Mr. Robert Neal Weingarten
-
Independent Chairman & Secretary
Mr. Robert Neal Weingarten
-
Headquarters
Houston, TX
-
Website
FAQs for Guardion Health Sciences (GHSI)
What is the current share price of Guardion Health Sciences Inc (GHSI) Today?
The share price of Guardion Health Sciences Inc (GHSI) is $3.22 (NASDAQ) as of 23-Jan-2025 09:30 EDT. Guardion Health Sciences Inc (GHSI) has given a return of -50.15% in the last 3 years.
What is the current PB & PE ratio of Guardion Health Sciences Inc (GHSI)?
Since, TTM earnings of Guardion Health Sciences Inc (GHSI) is negative, P/E ratio is not available.
The P/B ratio of Guardion Health Sciences Inc (GHSI) is 0.32 times as on 23-Jan-2025, a 96 discount to its peers’ median range of 7.75 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2023 |
43.09 |
0.84 |
2022 |
-0.01 |
0.01 |
2021 |
-31.94 |
35.44 |
2020 |
-0.04 |
0.04 |
2019 |
-0.01 |
0.01 |
What is the 52 Week High and Low of Guardion Health Sciences Inc (GHSI)?
The 52-week high and low of Guardion Health Sciences Inc (GHSI) are Rs -- and Rs -- as of 04-Sep-2026.
What is the market cap of Guardion Health Sciences Inc (GHSI)?
Guardion Health Sciences Inc (GHSI) has a market capitalisation of $ 4 Mln as on 23-Jan-2025. As per SEBI classification, it is a Small Cap company.
Should I invest in Guardion Health Sciences Inc (GHSI)?
Before investing in Guardion Health Sciences Inc (GHSI), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.